| Not Yet Recruiting | A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology NCT07481019 | National University Hospital, Singapore | N/A |
| Not Yet Recruiting | Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies NCT07228962 | King's College London | — |
| Not Yet Recruiting | The Impact of Dietary Salt on the Severity of Eczema NCT07447063 | University of California, San Francisco | Phase 4 |
| Recruiting | Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 NCT07453602 | Arcutis Biotherapeutics, Inc. | Phase 1 |
| Recruiting | Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema NCT07463079 | USMARI Research & Innovation Centre | N/A |
| Recruiting | Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD NCT07441395 | Corvus Pharmaceuticals, Inc. | Phase 2 |
| Not Yet Recruiting | Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis NCT07367932 | Cairo University | Phase 4 |
| Recruiting | Flourish: Exploring the Early Infant Gut Microbiome NCT07333482 | Seeding Inc | N/A |
| Not Yet Recruiting | Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective NCT07323394 | PeriPharm | — |
| Recruiting | A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe NCT06807268 | Pfizer | Phase 3 |
| Recruiting | A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) NCT07355075 | Turn Therapeutics | Phase 2 |
| Not Yet Recruiting | Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients NCT06702293 | National University Hospital, Singapore | N/A |
| Recruiting | A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic De NCT07037901 | Inmagene LLC | Phase 2 |
| Active Not Recruiting | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis NCT07011706 | Aclaris Therapeutics, Inc. | Phase 2 |
| Recruiting | Sodium in the Skin and Atopic Dermatitis NCT06998446 | University of California, San Francisco | — |
| Active Not Recruiting | Efficacy of Topical Cannabidiol for Eczema NCT06994520 | Khon Kaen University | Phase 2 |
| Enrolling By Invitation | A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous NCT06999941 | Xi Tan | — |
| Recruiting | Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. NCT06855745 | Alphyn Biologics | Phase 2 |
| Completed | Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis NCT06723405 | Evommune, Inc. | Phase 2 |
| Recruiting | A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations i NCT06815380 | Almirall, S.A. | — |
| Enrolling By Invitation | Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis NCT06464133 | University of Pennsylvania | — |
| Enrolling By Invitation | The Skin Microbiota in Skin Disease and Eczema NCT06924333 | Region Skane | — |
| Not Yet Recruiting | Educational Eczema Video Intervention NCT03664271 | Boston Children's Hospital | N/A |
| Completed | Eczeva Supplementation and Skin Health NCT07049770 | Zest Healthtech PLT | N/A |
| Recruiting | VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma NCT06570889 | Professor Klaus Bønnelykke | Phase 3 |
| Recruiting | Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma NCT06560255 | Professor Klaus Bønnelykke | Phase 3 |
| Recruiting | Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products I NCT06930365 | NAOS Les Laboratoires | N/A |
| Recruiting | LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema) NCT06584552 | The University of New South Wales | Phase 2 |
| Recruiting | Cardamom and Topical Roseomonas in Atopic Dermatitis NCT06096857 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis NCT06474728 | Children's Hospital of Fudan University | N/A |
| Recruiting | Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Der NCT06756438 | NAOS Les Laboratoires | N/A |
| Recruiting | A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis NCT06526182 | Almirall, S.A. | Phase 3 |
| Withdrawn | An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes NCT05873933 | Hemptress | N/A |
| Recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) NCT06353087 | Pfizer | — |
| Completed | A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis NCT06436183 | Apollo Therapeutics Ltd | Phase 2 |
| Unknown | Finding Patterns In Clinical Trial Experiences of Patients With Eczema NCT05747378 | Power Life Sciences Inc. | — |
| Completed | Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis NCT07537751 | Noura Abdelmoneim Mohammed Elseessy | N/A |
| Completed | Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms NCT06268847 | Abyss Ingredients | N/A |
| Recruiting | Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema NCT06155513 | SCF Pharma | N/A |
| Active Not Recruiting | Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic De NCT05990725 | Almirall, S.A. | Phase 3 |
| Active Not Recruiting | A Herbal Compound for Eczema NCT06758752 | Fasa University of Medical Sciences | Phase 2 |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Unknown | Molecular Diagnosis of Allergic Contact Dermatitis (SMECA). NCT06124781 | Ramsay Générale de Santé | N/A |
| Active Not Recruiting | Infant Restore: Efficacy of Microbiome Analysis and Education NCT06424691 | Seeding Inc | N/A |
| Recruiting | Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in NCT05758532 | Laure Pittet, MD-PhD | Phase 4 |
| Recruiting | A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. NCT05689151 | Pfizer | — |
| Enrolling By Invitation | A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <1 NCT05735483 | Eli Lilly and Company | Phase 3 |
| Unknown | Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema NCT05913791 | National University of Singapore | N/A |
| Completed | The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis NCT05770271 | Dove Medical Press Ltd | N/A |
| Terminated | A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) W NCT05732454 | Pfizer | Phase 2 / Phase 3 |
| Unknown | Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) NCT05473325 | Willows Health | — |
| Recruiting | Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada NCT05938478 | University of California, San Diego | — |
| Completed | Atopic Dermatitis With Accelerometry and Polysomnography (ADAP) NCT05583019 | SymmetryScience Group, Inc. | — |
| Active Not Recruiting | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopi NCT05559359 | Eli Lilly and Company | Phase 3 |
| Unknown | Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated NCT05413395 | GlycosBio, Inc. | N/A |
| Recruiting | Mother-Infant Cohort Study in Malaysia and China NCT04919265 | Universiti Putra Malaysia | — |
| Completed | Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use NCT04404075 | University of California, San Francisco | — |
| Completed | GB-EZ-SIM03 Probiotics Study for Childhood Eczema NCT05607511 | Chinese University of Hong Kong | N/A |
| Completed | Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% NCT05461456 | OrchestratePharma GmbH | Phase 1 |
| Unknown | Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province NCT05330637 | Shanghai Jiao Tong University School of Medicine | — |
| Unknown | Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. NCT05265234 | OptiSkin Medical | Phase 4 |
| Completed | A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) Th NCT05149313 | Almirall, S.A. | Phase 3 |
| Completed | Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study NCT05131477 | Kymab Limited | Phase 2 |
| Enrolling By Invitation | Quest to Analyze One Thousand Humans Meditating NCT06583395 | Tobias Moeller-Bertram | — |
| Completed | PGE2/IL-22 Pathway in Various Forms of Eczema NCT04133506 | NHS Lothian | — |
| Terminated | BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort NCT04818138 | Women's College Hospital | N/A |
| Unknown | A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients Wit NCT05439577 | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | — |
| Unknown | Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema NCT04617977 | The University of Hong Kong | N/A |
| Completed | Acceptance and Commitment Therapy-based Eczema Management Programme NCT04919330 | Chinese University of Hong Kong | N/A |
| Active Not Recruiting | Seal, Stopping Eczema and Allergy Study NCT03742414 | Kari Nadeau, MD, PhD | Phase 2 |
| Completed | A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe NCT04800315 | Celgene | Phase 2 |
| Completed | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With NCT04760314 | Eli Lilly and Company | Phase 3 |
| Unknown | Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring NCT04809571 | Institute of Bioengineering and Bioimaging (IBB) | N/A |
| Withdrawn | Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Bi NCT04965233 | Studies&Me | — |
| Completed | Blue Light in the Treatment of Inflammatory Skin Diseases NCT06516783 | Medical University of Lodz | N/A |
| Unknown | An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis NCT04520308 | Eric Simpson | Phase 4 |
| Completed | The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment NCT04358224 | Jonathan A. Bernstein, MD | Phase 4 |
| Completed | Joovvin' for Your Skin Health Study NCT04471896 | ProofPilot | N/A |
| Withdrawn | Glutamine Supplementation in People With Immune Dysregulation NCT04019769 | National Institute of Allergy and Infectious Diseases (NIAID) | EARLY_Phase 1 |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Eczema NCT04214548 | ProgenaBiome | — |
| Completed | Steroid-reducing Effects of Crisaborole NCT03832010 | Johns Hopkins University | Phase 4 |
| Completed | A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatiti NCT04021862 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Response of Children With Atopic Dermatitis (Eczema) to Eucrisa NCT04023084 | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 4 |
| Completed | Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis NCT03981926 | University of Southern California | N/A |
| Unknown | Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong NCT04154839 | The University of Hong Kong | — |
| Suspended | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469 | ProgenaBiome | — |
| Terminated | Evaluating the Effect of Bathing Additives in Atopic Dermatitis NCT04001855 | University of Arizona | N/A |
| Completed | Short-term Topical Application to Prevent Atopic Dermatitis NCT03871998 | University College Cork | N/A |
| Completed | A Clinical Investigation With Epaderm® Cream NCT03738163 | Molnlycke Health Care AB | N/A |
| Terminated | The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis NCT03775590 | Mayo Clinic | N/A |
| Completed | Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) NCT03823794 | Momentum Data | — |
| Completed | Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema NCT04986384 | Prof. HON Kam Lun Ellis | N/A |
| Completed | Paraffin Bath Therapy for Chronic Hand Eczema NCT04510961 | Cairo University | N/A |
| Completed | A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis NCT03775434 | AOBiome LLC | Phase 1 |
| Completed | Eczema Reminder and Accountability Program NCT03735459 | McMaster University | N/A |
| Completed | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe At NCT03720470 | Pfizer | Phase 3 |
| Completed | Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis NCT03293030 | University of California, San Francisco | Phase 4 |
| Completed | The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Ch NCT03873142 | University of Sheffield | N/A |
| Completed | Effect of Benralizumab in Atopic Dermatitis NCT03563066 | McMaster University | Phase 2 |
| Completed | Bone Health in Patients With Atopic Dermatitis NCT03800004 | Mayo Clinic | — |
| Completed | A Community-based Assessment of Skin Care, Allergies, and Eczema NCT03409367 | Oregon Health and Science University | N/A |
| Completed | Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema NCT03619161 | University of North Carolina, Chapel Hill | N/A |
| Completed | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Se NCT03627767 | Pfizer | Phase 3 |
| Completed | CYPHP Evelina London Evaluation NCT03461848 | Guy's and St Thomas' NHS Foundation Trust | N/A |
| Active Not Recruiting | The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants NCT03667651 | University of Melbourne | Phase 3 |
| Completed | Mast Cell Activation Test in Allergic Disease NCT03406325 | Hong Kong Sanatorium & Hospital | — |
| Unknown | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases NCT03340155 | Medical University of Graz | N/A |
| Withdrawn | Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy NCT03089476 | National Jewish Health | N/A |
| Completed | An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema NCT03160248 | Technical University of Munich | Phase 2 |
| Unknown | A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World NCT03192748 | China Academy of Chinese Medical Sciences | — |
| Completed | Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema NCT03134352 | Zai Lab Pty. Ltd. | Phase 2 |
| Completed | A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis NCT02871479 | Santalis Pharmaceuticals, Inc. | Phase 2 |
| Completed | A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis NCT03089229 | Haus Bioceuticals | Phase 1 / Phase 2 |
| Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Spec NCT02916888 | Yale University | — |
| Withdrawn | Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival NCT01960764 | University of California, San Diego | Phase 1 |
| Completed | A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin NCT02620293 | Reckitt Benckiser Healthcare (UK) Limited | Phase 1 |
| Completed | Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis NCT02732314 | Procter & Gamble Beauty | Phase 4 |
| Terminated | Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients NCT02713035 | University of Mississippi Medical Center | N/A |
| Unknown | Ganoderma Tea on Eczema Patient NCT02533635 | Hong Kong Baptist University | Phase 1 / Phase 2 |
| Unknown | Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research NCT02517957 | Shanghai Yueyang Integrated Medicine Hospital | Phase 2 |
| Withdrawn | Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patient NCT02144142 | University of California, San Diego | Phase 2 |
| Completed | Randomized Controlled Trial of an Eczema Care Plan NCT02251340 | Boston Children's Hospital | N/A |
| Unknown | PatientSpot Formerly Known as ArthritisPower NCT03840928 | Global Healthy Living Foundation | — |
| Completed | Sleep, Circadian Rhythm & Skin Health NCT02457000 | University Hospitals Cleveland Medical Center | — |
| Terminated | Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin NCT02404493 | Johnson & Johnson Consumer Inc. (J&JCI) | N/A |
| Unknown | Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis NCT02286700 | NeoStrata Company, Inc. | Phase 3 |
| Completed | Barrier Enhancement for Eczema Prevention NCT04680520 | University of Nottingham | N/A |
| Completed | ADRN Barrier/Immunoprofiling Exploratory Pilot Study NCT02115399 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin NCT02120833 | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 3 |
| Completed | DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study NCT02379507 | Medicus Research, LLC | Phase 1 |
| Completed | Blue Light for Treating Eczema NCT02002871 | Philips Electronics Nederland BV | N/A |
| Completed | Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Derma NCT01916980 | Organon and Co | Phase 3 |
| Completed | Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction NCT01906853 | Murdoch Childrens Research Institute | Phase 3 |
| Terminated | A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema NCT01826630 | Shari L Hand | N/A |
| Unknown | Vitamin A Supplementation at Birth and Atopy in Childhood NCT01779180 | Bandim Health Project | — |
| Active Not Recruiting | Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis NCT01782703 | Northwestern University | — |
| Completed | A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients NCT01714245 | TopMD Skin Care, Inc. | — |
| Recruiting | Effects of Treatments on Atopic Dermatitis NCT01631617 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 2 |
| Completed | Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatme NCT01257061 | EMS | Phase 3 |
| Completed | A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema NCT01899287 | University of Copenhagen | N/A |
| Terminated | Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis NCT01577628 | Cosmetique Active International | N/A |
| Completed | Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatit NCT01429701 | EMS | Phase 3 |
| Unknown | Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Deve NCT01473823 | Ostergotland County Council, Sweden | N/A |
| Unknown | Intestinal Microbiota Composition After Antibiotic Treatment in Early Life NCT02536560 | Agentschap NL | — |
| Completed | Bacille Calmette-Guérin (BCG) Vaccine and Atopy NCT01420705 | Bandim Health Project | — |
| Completed | HPA Axis Study in Adults NCT01408511 | Bayer | Phase 2 |
| Completed | HPA Axis Study in Japanese Adults NCT01407510 | Bayer | Phase 2 |
| Completed | Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) NCT01359787 | Bayer | Phase 2 |
| Completed | Persistence of Oral Tolerance to Peanut NCT01366846 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Withdrawn | Management of Eczema by Specific Probiotic Strains NCT01230190 | Agentschap NL | Phase 3 |
| Completed | The Effects of Emollient Therapy on the Skin Barrier NCT01291940 | Oregon Health and Science University | N/A |
| Completed | Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases NCT01254240 | University of Zurich | Phase 2 |
| Completed | Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy NCT01149759 | Rockefeller University | N/A |
| Completed | Group Eczema Education Visits:Impact on Patient and Family Quality of Life NCT01143012 | Oregon Health and Science University | N/A |
| Unknown | Feasibility Study of Barrier Enhancement for Eczema Prevention NCT01142999 | Oregon Health and Science University | N/A |
| Completed | Cooling Pillow for Atopic Dermatitis NCT01132651 | Northwestern University | N/A |
| Terminated | A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis NCT01122914 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With A NCT01202149 | Frankel, Amylynne, M.D. | Phase 4 |
| Completed | Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema NCT01020994 | Almirall, S.A. | Phase 2 |
| Unknown | A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema NCT01012453 | Zealand University Hospital | N/A |
| Completed | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema NCT00817063 | Stiefel, a GSK Company | Phase 3 |
| Active Not Recruiting | Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood NCT00798226 | Copenhagen Studies on Asthma in Childhood | Phase 1 |
| Unknown | The Cork BASELINE Birth Cohort Study NCT01498965 | National Children's Research Centre, Ireland | — |
| Terminated | Hydrogel Patch for the Treatment of Eczema NCT00924508 | University of California, San Francisco | N/A |
| Completed | Potential Research Study Participant Registry NCT00710489 | University of California, Davis | — |
| Completed | Care of the Dry Skin With Physiogel AI Lotion® (W0156) NCT00663364 | University Hospital Muenster | N/A |
| Completed | Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects Wit NCT01567995 | GlaxoSmithKline | Phase 3 |
| Recruiting | Studies of Skin Microbes in Healthy People and in People With Skin Conditions NCT00605878 | National Human Genome Research Institute (NHGRI) | — |
| Completed | Alitretinoin in the Treatment of Chronic Hand Eczema NCT00519675 | Basilea Pharmaceutica | Phase 3 |
| Unknown | Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis NCT00465699 | Spartanburg Regional Healthcare System | N/A |
| Completed | Oral Bacteria and Allergic Disease in Children NCT00438646 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Completed | Promoting Tolerance to Peanut in High-Risk Children NCT00329784 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream NCT02075632 | GlaxoSmithKline | Phase 2 |
| Completed | Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years NCT00365469 | National University Hospital, Singapore | Phase 2 |
| Completed | Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development NCT00713089 | National University Hospital, Singapore | — |
| Completed | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizi NCT00375713 | UCB Pharma | Phase 3 |
| Terminated | Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis NCT00143819 | University of Medicine and Dentistry of New Jersey | Phase 2 |
| Completed | Risk of Asthma in Infants With Atopic Dermatitis NCT00459576 | Indiana University School of Medicine | — |
| Recruiting | Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research NCT00177268 | University of Pittsburgh | — |
| Completed | Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses NCT00318695 | National University Hospital, Singapore | Phase 2 |
| Completed | Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) NCT00076375 | Nucryst Pharmaceuticals | Phase 2 |
| Completed | Probiotics in Prevention of Allergies, Obesity and Caries NCT00894816 | Umeå University | N/A |